Basel Medical Group Ltd (BMGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | |
| Sales | 8,900 | 7,417 |
| Cost of Goods | 1,986 | 1,659 |
| Gross Profit | 6,914 | 5,758 |
| Operating Expenses | 8,809 | 4,512 |
| Operating Income | -909 | 1,904 |
| Interest Expense | 160 | 130 |
| Other Income | -8,763 | 0 |
| Pre-tax Income | -9,832 | 1,774 |
| Income Tax | -328 | 245 |
| Net Income Continuous | -9,504 | 1,530 |
| Net Income | $-9,504 | $1,530 |
| EPS Basic Total Ops | -0.51 | 0.09 |
| EPS Basic Continuous Ops | -0.51 | 0.09 |
| EPS Diluted Total Ops | -0.51 | 0.09 |
| EPS Diluted Continuous Ops | -0.51 | 0.09 |
| EPS Diluted Before Non-Recurring Items | -0.04 | N/A |
| EBITDA(a) | $-824 | $1,927 |